Alagille Syndrome - 13 Studies Found Status Study Completed Study Name: Positional Cloning of the Gene(s) Responsible for Alagille Syndrome Condition: Alagille Syndrome Date: 2000-04-06 Recruiting Study Name: Characterization of Pulmonary Artery Stenoses in Alagille Syndrome - a Medical Record Review Condition: Alagille Syndrome Date: 2012-01-18 Completed Study Name: Evaluation of LUM001 in the Reduction of Pruritus in Alagille Syndrome Condition: Alagille Syndrome Date: 2014-02-05 Interventions: Drug: LUM001 LUM001 administer Active, not recruiting Study Name: A Long-Term, Open-Label Study of LUM001 With a Double-Blind, Placebo Controlled, Randomized Drug Withdrawal Period to Evaluate Safety and Efficacy in Children With Alagille Syndrome Condition: Alagille Syndrome Date: 2014-06-09 Interventions: Drug: LUM001 LUM001 administer Completed Study Name: Safety and Efficacy Study of LUM001 in the Treatment of Cholestatic Liver Disease in Patients With Alagille Syndrome Condition: Alagille Syndrome Date: 2013-07-16 Interventions: Drug: LUM001 Drug: Placebo Active, not recruiting Study Name: An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Subjects With Alagille Syndrome (ALGS) Condition: Alagille Syndrome Date: 2014-01-23 Interventions: Drug: LUM001 Dosing of LUM001 with the objective of achieving optimal control of pruritus at a dose leve Active, not recruiting Study Name: An Extension Study to Evaluate the Long-Term Safety and Durability of Effect of LUM001 in the Treatment of Cholestatic Liver Disease in Pediatric Subjects With Alagille Syndrome Condition: Alagille Syndrome Date: 2014-04-16 Interventions: Drug: LUM001 Administered orally daily Completed Study Name: Validation of the Itch Reported Outcome (ItchRO) Diaries in Pediatric Cholestatic Liver Disease Condition: Alagille Syndrome Progressive Familial Intrahepatic Cholestasis Date: 2014-05-01 Completed Study Name: Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease Condition: Alagille Syndrome Cholestasis Date: 2000-12-06 Interventions: Drug: magnesium gluconate Drug: magnesium Recruiting Study Name: Evaluating the Genetic Causes and Progression of Cholestatic Liver Diseases (LOGIC) Condition: Liver Diseases Alagille Syndrome Join Millions Sign Up For One Of Our Newsletters Email Sign Up